46 related articles for article (PubMed ID: 11289121)
1. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
[TBL] [Abstract][Full Text] [Related]
2. Expression of P-glycoprotein, Cyclin D1 and Ki-67 in Acute Lymphoblastic Leukemia: Relation with Induction Chemotherapy and Overall Survival.
Elsayed GM; Ismail MM; Moneer MM
Indian J Hematol Blood Transfus; 2011 Sep; 27(3):157-63. PubMed ID: 22942566
[TBL] [Abstract][Full Text] [Related]
3. Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study.
Zhang C; Xu L; Ma Y; Huang Y; Zhou L; Le H; Chen Z
J Thorac Dis; 2023 Mar; 15(3):1433-1444. PubMed ID: 37065598
[TBL] [Abstract][Full Text] [Related]
4. Cellular senescence in cancer: clinical detection and prognostic implications.
Domen A; Deben C; Verswyvel J; Flieswasser T; Prenen H; Peeters M; Lardon F; Wouters A
J Exp Clin Cancer Res; 2022 Dec; 41(1):360. PubMed ID: 36575462
[TBL] [Abstract][Full Text] [Related]
5. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y
Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of cellular senescence in resected non-small cell lung cancer.
Domen A; Deben C; De Pauw I; Hermans C; Lambrechts H; Verswyvel J; Siozopoulou V; Pauwels P; Demaria M; van de Wiel M; Janssens A; Hendriks JMH; Van Schil P; Vermorken JB; Vandamme T; Prenen H; Peeters M; Lardon F; Wouters A
Transl Lung Cancer Res; 2022 Aug; 11(8):1526-1539. PubMed ID: 36090630
[TBL] [Abstract][Full Text] [Related]
7. Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation.
Yan J; Wu L; Jia C; Yu S; Lu Z; Sun Y; Chen J
Aging (Albany NY); 2020 Feb; 12(4):3747-3770. PubMed ID: 32081836
[TBL] [Abstract][Full Text] [Related]
8. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers in lung cancer: is it ready for prime time?
Zhu CQ; Tsao MS
Transl Lung Cancer Res; 2014 Jun; 3(3):149-58. PubMed ID: 25806294
[TBL] [Abstract][Full Text] [Related]
10. Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G.
Xu X; Liu S; Lei B; Li W; Lin N; Sheng W; Huang A; Shen H
Mol Cell Biochem; 2013 Nov; 383(1-2):1-11. PubMed ID: 24013786
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.
Scheffler M; Zander T; Nogova L; Kobe C; Kahraman D; Dietlein M; Papachristou I; Heukamp L; Büttner R; Boellaard R; Lammertsma AA; Querings S; Stoelben E; Engel-Riedel W; Neumaier B; Wolf J
PLoS One; 2013; 8(1):e53081. PubMed ID: 23308140
[TBL] [Abstract][Full Text] [Related]
12. A Perturbation Method for Inference on Regularized Regression Estimates.
Minnier J; Tian L; Cai T
J Am Stat Assoc; 2011 Jan; 106(496):1371-1382. PubMed ID: 22844171
[TBL] [Abstract][Full Text] [Related]
13. Role of cell cycle regulators in lung carcinogenesis.
Eymin B; Gazzeri S
Cell Adh Migr; 2010; 4(1):114-23. PubMed ID: 20139697
[TBL] [Abstract][Full Text] [Related]
14. Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.
Hittelman WN; Liu DD; Kurie JM; Lotan R; Lee JS; Khuri F; Ibarguen H; Morice RC; Walsh G; Roth JA; Minna J; Ro JY; Broxson A; Hong WK; Lee JJ
J Natl Cancer Inst; 2007 Nov; 99(21):1603-12. PubMed ID: 17971525
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.
Yamamoto Y; Nishiyama Y; Kimura N; Ishikawa S; Okuda M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):236-45. PubMed ID: 17909790
[TBL] [Abstract][Full Text] [Related]
16. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.
Yamamoto Y; Nishiyama Y; Ishikawa S; Nakano J; Chang SS; Bandoh S; Kanaji N; Haba R; Kushida Y; Ohkawa M
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1610-6. PubMed ID: 17530250
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis.
Yoo J; Jung JH; Lee MA; Seo KJ; Shim BY; Kim SH; Cho DG; Ahn MI; Kim CH; Cho KD; Kang SJ; Kim HK
J Korean Med Sci; 2007 Apr; 22(2):318-25. PubMed ID: 17449943
[TBL] [Abstract][Full Text] [Related]
18. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.
Ma Y; Fiering S; Black C; Liu X; Yuan Z; Memoli VA; Robbins DJ; Bentley HA; Tsongalis GJ; Demidenko E; Freemantle SJ; Dmitrovsky E
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4089-94. PubMed ID: 17360482
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
Zhu CQ; Shih W; Ling CH; Tsao MS
J Clin Pathol; 2006 Aug; 59(8):790-800. PubMed ID: 16873561
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of imaging proliferative activity in lung nodules.
Buck AK; Hetzel M; Schirrmeister H; Halter G; Möller P; Kratochwil C; Wahl A; Glatting G; Mottaghy FM; Mattfeldt T; Neumaier B; Reske SN
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):525-33. PubMed ID: 15599526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
